[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016 US PT and APTT Point-of-Care/POC Testing Markets: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

October 2015 | 337 pages | ID: 2068DAD9C45EN
Venture Planning Group

US$ 2,320.00 US$ 2,900.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 337-page report from VPGMarketResearch.com contains 31 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis- Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and reagent sales forecasts for coagulation procedures by market segment: - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth CentersSales and Market Share Analysis- Sales and market shares of major reagent and instrument suppliers. Current and Emerging Products- Analysis of coagulation procedures performed in POC testing locations. - Review of leading coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. Technology Review- Emerging technologies and their applications for POC testing. - Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.

Competitive Assessments

Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations- Specific opportunities for new coagulation instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products. - Alternative business expansion strategies.
  • Potential market entry barriers and risks.

    Methodology

    Thiis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

    Contains 337 pages and 31 tables
  • INTRODUCTION

    EXECUTIVE SUMMARY
    Rationale for Testing Decentralization
      1. Overview
      2. Regulatory Trends
      3. Economic Trends
      4. Demographic Trends
      5. Technological Trends
      6. Social Trends
      7. Quality of Care
      8. Defensive Medicine
      9. Quality Control Issues

    WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    1. Introduction
    2. Activated Partial Thromboplastin Time (APTT)
    3. Prothrombin Time (PT)
      Instrumentation: Coagulation Analyzers Manufactured by:
      Behnk Elektronik
      Bio/Data
      Cardiovascular Diagnostics
      Diagnostica Stago
      Helena Laboratories
      Instrumentation Laboratory
      ITC Hemochron
      Roche
      Siemens
      Sysmex
      Teco Medical Instruments
      Trinity Biotech
    Current and Emerging Technologies
      1. Monoclonal Antibodies
      2. Immunoassays
        a. Technological Principle
        b. Enzyme Immunoassays (EIA)
          Overview
          ELISA
          Dot Immunobinding Assays
          Capillary Immunoassays
          Particle-Membrane Capture Immunoassay
          Enzyme Amplification
        c. Fluorescent Immunoassays
          Fluorescent Polarization
          Time-Resolved Pulse Fluorescence
        d. Luminescence
          Chemiluminescence
          Bioluminescence
        e. Latex Agglutination
        f. Immunoprecipitation
      3. Dry Chemistry
      4. Biosensors
      5. IT and Automation
      6. Molecular Diagnostics
        a. Technology Overview
        b. Amplification Methods
          Polymerase Chain Reaction
          Ligase Chain Reaction
          Branched DNA
          Q-Beta Replicase
          Strand Displacement Activation
          Self-Sustained Sequence Replicase

    U.S.A.

    A. Market Overview
      1. Business Environment
        a. Health Care Expenditures
        b. Cost Consciousness
        c. Reimbursement
        d. Industry Consolidation
        e. Managed Care
          PPO
          HMO
        f. Hospitals
        g. Admissions
        h. Length of Stay
        i. Industry Diversification
        j. Physician Demographics
        k. Aging Population
          More Chronic Illness
          Disease Incidence
          Susceptibility to latrogenesis
          Multiple Illnesses Cases
        l. Laboratory Regulations
      2. Market Structure
        a. Hospitals
        b. Commercial/Private Laboratories
    B. Physician Offices/Group Practices
      1. Market Summary
      2. Market Structure
      3. Test Volume and Sales Forecasts
    C. Ancillary Hospital Locations
      1. Introduction
        a. Emergency Departments
        b. Operating Suites
        c. Intensive Care Units
      2. Emergency Departments
        a. Market Summary
        b. Test volume and Sales Forecasts
      3. Operating and Recovery Suites
        a. Market Summary
        b. Test Volume and Sales Forecasts
      4. ICUs/CCUs
        a. Market Summary
        b. Test Volume and Sales Forecasts
    D. Cancer Clinics
      1. Introduction
      2. Market Summary
      3. Test Volume and Sales Forecasts
    E. Ambulatory Care Centers
      1. Introduction
      2. Market Summary
      3. Market Structure
      4. Test Volume and Sales Forecasts
    F. Surgery Centers
      1. Introduction
      2. Market Summary
      3. Market Structure
      4. Test Volume and Sales Forecasts
    G. Nursing Homes
      1. Introduction
      2. Market Summary
      3. Market Structure
      4. Test Volume and Sales Forecasts
    H. Birth Centers
      1. Introduction
      2. Market Summary
      3. Market Structure
      4. Test Volume and Sales Forecasts
    I. Major Suppliers’ Instrument Placements, Installed Base, Consumables Sales and Market Shares

    MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    A. Routine and Special Chemistry
    B. Microbiology/Infectious Diseases
    C. Hematology and Flow Cytometry
    D. Coagulation

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. Marketing Approaches
      2. Product complexity
      3. Customer Preference
      4. Established Suppliers
      5. Emerging Suppliers
      6. Major Types of Distributors
      7. Market Segmentation

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    COMPANY PROFILE

    Abbott
    ADI/America Diagnostica
    Agilent Technologies
    Axis-Shield
    Beckman Coulter/Danaher
    Becton Dickinson
    Bio/Data
    Biomerieux
    Bio-Rad
    Biosite/Inverness/Alere
    Cephid
    Chrono-Log
    Corgenix
    Decode
    Diadexus
    Diagnocure
    Diagnostica Stago/Trinity Biotech
    Diamedix
    Diasorin
    Eiken Chemical
    EKF Diagnostics
    Fujirebio/Innogenetics
    Helena Laboratories
    Hologic/Gen-Probe
    Horiba
    Instrumentation Laboratory
    International Technidyne/Nexus DX
    Kreatech
    Kyowa Medex
    Life Technologies
    Lonza
    Mackay Life Sciences
    Matritech
    Nihon Kohden
    Ortho-Clinical Diagnostics
    Polartechnics
    Polymedco
    Qiagen
    Roche
    SDIX
    Sequenom
    Siemens
    Sienco
    Sysmex
    Takara Bio
    ThermoFisher
    Tosoh
    Wako
    Zycare/Alere

    LIST OF TABLES

    Major Companies Developing or Marketing APTT Tests
    Major Companies Developing or Marketing PT Tests
    U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
    U.S.A., Physician Offices/Group Practices Forecast by Type
    U.S.A., Office-Based Physicians Forecast by Practice Type
    U.S.A., Physician Offices/Group Practices PT and APTT Test Volume Forecast
    U.S.A., Physician Offices/Group Practices Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Ancillary Hospital Locations Estimated Number
    U.S.A., Ancillary Hospital Locations Annual Utilization
    U.S.A., Hospital Emergency Departments PT and APTT Test Volume Forecast
    U.S.A., Hospital Emergency Departments Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Hospital Operating and Recovery Suites PT and APTT Test Volume Forecast
    U.S.A., Hospital Operating and Recovery Suites Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Hospital ICUs/CCUs PT and APTT Test Volume Forecast
    U.S.A., Hospital ICUs/CCUs Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Cancer Clinics Major PT and APTT Test Volume Forecast
    U.S.A., Cancer Clinics Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
    U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
    U.S.A., Ambulatory Care Centers PT and APTT Test Volume Forecast
    U.S.A., Ambulatory Care Centers Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Surgery Centers Most Frequently Performed Procedures
    U.S.A., Surgery Centers PT and APTT Test Volume Forecast
    U.S.A., Surgery Centers Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
    U.S.A., Nursing Homes PT and APTT Test Volume Forecast
    U.S.A., Nursing Homes Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Birth Centers Facilities, Patient Visits, and Births
    U.S.A., Birth Centers PT and APTT Test Volume Forecast
    U.S.A., Birth Centers Coagulation Reagent and Instrument Sales Forecast
    U.S.A., Major Suppliers of Coagulation Diagnostic Products Estimated Market Shares


    More Publications